Cargando…

A Novel Anti-Kv10.1 Nanobody Fused to Single-Chain TRAIL Enhances Apoptosis Induction in Cancer Cells

Antibody-based therapies hold promise for a safe and efficient treatment of cancer. The identification of target tumor cells through a specific antigen enriched on their surface and the subsequent delivery of the therapeutic agent only to those cells requires, besides the efficacy of the therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hartung, Franziska, Krüwel, Thomas, Shi, Xiaoyi, Pfizenmaier, Klaus, Kontermann, Roland, Chames, Patrick, Alves, Frauke, Pardo, Luis A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246340/ https://www.ncbi.nlm.nih.gov/pubmed/32528281 http://dx.doi.org/10.3389/fphar.2020.00686

Ejemplares similares

Guiding TRAIL to cancer cells through Kv10.1 potassium channel overcomes resistance to doxorubicin
por: Hartung, Franziska, et al.
Publicado: (2016)

In vivo detection of small tumour lesions by multi-pinhole SPECT applying a (99m)Tc-labelled nanobody targeting the Epidermal Growth Factor Receptor
por: Krüwel, Thomas, et al.
Publicado: (2016)

Tumor cell-selective apoptosis induction through targeting of K(V)10.1 via bifunctional TRAIL antibody
por: Hartung, Franziska, et al.
Publicado: (2011)

IgG-single-chain TRAIL fusion proteins for tumour therapy
por: Siegemund, Martin, et al.
Publicado: (2018)

Targeting scFv-Fc-scTRAIL fusion proteins to tumor cells
por: Hutt, Meike, et al.
Publicado: (2018)

Special Issue: Nanobody
por: Chames, Patrick, et al.
Publicado: (2020)

In vivo imaging of tumour xenografts with an antibody targeting the potassium channel K(v)10.1
por: Napp, Joanna, et al.
Publicado: (2016)

Kv10.1 Regulates Microtubule Dynamics during Mitosis
por: Movsisyan, Naira, et al.
Publicado: (2020)

Superior antitumoral activity of dimerized targeted single-chain TRAIL fusion proteins under retention of tumor selectivity
por: Siegemund, M, et al.
Publicado: (2012)

Nanobody Engineering: Toward Next Generation Immunotherapies and Immunoimaging of Cancer
por: Chanier, Timothée, et al.
Publicado: (2019)

EGFR-Targeted TRAIL and a Smac Mimetic Synergize to Overcome Apoptosis Resistance in KRAS Mutant Colorectal Cancer Cells
por: Möller, Yvonne, et al.
Publicado: (2014)

Selective Targeting of TNF Receptors as a Novel Therapeutic Approach
por: Fischer, Roman, et al.
Publicado: (2020)

Inhibition of Kv10.1 Channels Sensitizes Mitochondria of Cancer Cells to Antimetabolic Agents
por: Hernández-Reséndiz, Ileana, et al.
Publicado: (2020)

Monitoring extracellular ion and metabolite dynamics with recombinant nanobody-fused biosensors
por: Burgstaller, Sandra, et al.
Publicado: (2022)

Potent antitumoral activity of TRAIL through generation of tumor-targeted single-chain fusion proteins
por: Schneider, B, et al.
Publicado: (2010)

The Kv10.1 Channel: A Promising Target in Cancer
por: Luis, Enoch, et al.
Publicado: (2022)

Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics
por: Bannas, Peter, et al.
Publicado: (2017)

Single- and two-photon imaging of human micrometastases and disseminated tumour cells with conjugates of nanobodies and quantum dots
por: Ramos-Gomes, Fernanda, et al.
Publicado: (2018)

Low-Level Endothelial TRAIL-Receptor Expression Obstructs the CNS-Delivery of Angiopep-2 Functionalised TRAIL-Receptor Agonists for the Treatment of Glioblastoma
por: Krishna Moorthy, Nivetha, et al.
Publicado: (2021)

Analysis of the expression of Kv10.1 potassium channel in patients with brain metastases and glioblastoma multiforme: impact on survival
por: Martínez, Ramón, et al.
Publicado: (2015)

Antitumor Activity of a Mesenchymal Stem Cell Line Stably Secreting a Tumor-Targeted TNF-Related Apoptosis-Inducing Ligand Fusion Protein
por: Marini, Irene, et al.
Publicado: (2017)

Fc-based Duokines: dual-acting costimulatory molecules comprising TNFSF ligands in the single-chain format fused to a heterodimerizing Fc (scDk-Fc)
por: Aschmoneit, Nadine, et al.
Publicado: (2022)

Intracellular hemin is a potent inhibitor of the voltage-gated potassium channel Kv10.1
por: Sahoo, Nirakar, et al.
Publicado: (2022)

Duokines: a novel class of dual-acting co-stimulatory molecules acting in cis or trans
por: Fellermeier-Kopf, Sina, et al.
Publicado: (2018)

Antagonistic TNF Receptor One-Specific Antibody (ATROSAB): Receptor Binding and In Vitro Bioactivity
por: Richter, Fabian, et al.
Publicado: (2013)

Rapid nanobody-based imaging of mesothelin expressing malignancies compatible with blocking therapeutic antibodies
por: Benloucif, Abdennour, et al.
Publicado: (2023)

Novel recombinant immunotoxin of EGFR specific nanobody fused with cucurmosin, construction and antitumor efficiency in vitro
por: Deng, Cuimin, et al.
Publicado: (2017)

Target protein deglycosylation in living cells by a nanobody-fused split O-GlcNAcase
por: Ge, Yun, et al.
Publicado: (2021)

Sensitization of glioblastoma cells to TRAIL-induced apoptosis by IAP- and Bcl-2 antagonism
por: Lincoln, Frank A., et al.
Publicado: (2018)

Periodic expression of Kv10.1 driven by pRb/E2F1 contributes to G2/M progression of cancer and non-transformed cells
por: Urrego, Diana, et al.
Publicado: (2016)

Convergence of pathway analysis and pattern recognition predicts sensitization to latest generation TRAIL therapeutics by IAP antagonism
por: Vetma, Vesna, et al.
Publicado: (2020)

Superior Treg-Expanding Properties of a Novel Dual-Acting Cytokine Fusion Protein
por: Padutsch, Tanja, et al.
Publicado: (2019)

Enacting Phenomenological Gestalts in Ultra-Trail Running: An Inductive Analysis of Trail Runners’ Courses of Experience
por: Rochat, Nadège, et al.
Publicado: (2018)

Klaviersonaten, KV 310, KV 333, KV 545
por: Mozart, Wolfgang Amadeus, 1756-1791
Publicado: (1989)

Novel strategies to mimic transmembrane tumor necrosis factor-dependent activation of tumor necrosis factor receptor 2
por: Fischer, Roman, et al.
Publicado: (2017)

Recombinant expression of nanobodies and nanobody-derived immunoreagents
por: de Marco, Ario
Publicado: (2020)

Focal adhesion kinase plays a dual role in TRAIL resistance and metastatic outgrowth of malignant melanoma
por: Del Mistro, Greta, et al.
Publicado: (2022)

Kv5, Kv6, Kv8, and Kv9 subunits: No simple silent bystanders
por: Bocksteins, Elke
Publicado: (2016)

Co-modulation of TNFR1 and TNFR2 in an animal model of multiple sclerosis
por: Fiedler, Timon, et al.
Publicado: (2023)

A comprehensive comparison between camelid nanobodies and single chain variable fragments
por: Asaadi, Yasaman, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k91hshapojplhg8psn7jnjukmn